Akari Therapeutics, Plc (AKTX)

USD 0.96

(-3.99%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 4000.00 3708.00 4126.00 8907.00 19.2 Thousand 35.84 Thousand
Gross Profit -4000.00 -3708.00 -4126.00 -8907.00 -19.2 Thousand -35.84 Thousand
Operating Expenses 16.8 Million 23.89 Million 17.21 Million 20.1 Million 24.88 Million 23.8 Million
Selling, General and Administrative Expenses 11.35 Million 13.52 Million 8.08 Million 7.91 Million 8.22 Million 10.89 Million
Research and Development Expenses 12.13 Million 9.56 Million 9.13 Million 12.19 Million 16.64 Million 15.58 Million
Other Expenses -6.68 Million 802.79 Thousand -27.48 Thousand -22 Thousand 19 Thousand -2.68 Million
Cost and Expenses 16.8 Million 23.08 Million 17.21 Million 20.1 Million 24.88 Million 23.8 Million
Operating Income -16.8 Million -23.08 Million -17.21 Million -17.98 Million -24.87 Million -19.99 Million
Interest Expense - - - - - -
Income Tax Expense - -10.77 Million 182.61 Thousand -2.85 Million -2.98 Million -3.55 Million
Earnings before Tax -10 Million -17.74 Million -17.42 Million -20.45 Million -24.75 Million -23.5 Million
Net Income -10 Million -6.97 Million -17.6 Million -17.59 Million -21.76 Million -19.95 Million
Earnings Per Share Basic -2.04 -2.23 -8.20 -11.14 -23.77 -1.26
Earnings Per Share Diluted -2.04 -2.23 -8.20 -11.14 -23.77 -1.26
Weighted Average Shares Outstanding 4.89 Million 3.12 Million 2.14 Million 1.57 Million 915.49 Thousand 15.8 Million
Weighted Average Shares Outstanding (Diluted) 4.89 Million 3.12 Million 2.14 Million 1.57 Million 915.49 Thousand 15.8 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -16.8 Million -23.08 Million -17.21 Million -20.44 Million -24.73 Million -16.43 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts